ARECOR THERAPEUTICS -,01

WHO'M

Digital Profiler. Simply click the AI button

CUSIP

N/A

SEDOL

BMWLM97

CIK

N/A

LEI:

FIGI: BBG011354DQ0

AREC

ARECOR THERAPEUTICS -,01

GICS: - · Sector: Health Care · Sub-Sector: Health Care

PROFILER

NAME

ARECOR THERAPEUTICS -,01

ISIN

GB00BMWLM973

TICKER

AREC

MIC

AIMX

REUTERS

AREC.L

BLOOMBERG

AREC LN

BUILD THEMEFOLIO SHARE IDEAS DISCUSS

LEVERAGE INVEST

Financial Intelligence

360°^iHub Crowd^iFeed ATH Tracker Index Tracker ETF TF Spicy² X-Billboard

FOR INVESTORS

FOR TRADERS

Securities Trading Warrants

GlobeNewswire is an important news source that provides investors with company-related information. In particular, it deals with events that may be relevant to the listing of companies or tradable financial instruments. You can access the complete overview of all reports via this link.

Mon, 20.05.2024

Arecor Therapeutics plc
(“Arecor” or “the Company”)

Research & Analysis

Thu, 09.05.2024

Arecor Therapeutics plc
(“Arecor” or the “Company”)

Research & Analysis

We are different

OPEN FINANCIAL

DATA & KNOWLEDGE HUB

We make the difference

Information on product placements

Legend

SMART * AD

P R O D U C T S U G G E S T I O N S

First Name *

Last Name

Email *

Subject *

i.e Feature x is not working

Issue happened on *

This page

Other page

Bug Detail *

Please give us more detailed explanation of the issue

Steps to reproduce *

Specify the steps you've done before the issue happen

Actual Result *

What's the result of the issue?

Expected Result *

What do you expect to see?

Attachment

(Optional) You can send us a screenshot, word document, or a PDF explaining the issue

Please log in to your user account. This will allow us to contact you in case of any queries.

I would like to remain anonymous.

ARECOR THERAPEUTICS -,01

At278 Ultra-Concentrated Ultra-Rapid Acting Insulin Demonstrates Superiority in Phase i Clinical Trial in Overweight and Obese People With Type 2 Diabetes

Arecor and Medtronic Diabetes establish collaboration to develop a novel thermostable insulin for implantable pump delivery

Newsletter